Download

Audience for the document: Share Class: Language of the document:

Download

Share Class: Language of the document:

Change Details

If you need to change your email address please contact us.
Subscriptions
OK
You are ready to start subscribing.
Get started by going to our products or insights section to follow what you're interested in.

Products Insights

GIPS® Information

T. Rowe Price ("TRP") claims compliance with the Global Investment Performance Standards (GIPS®) and has prepared and presented this report in compliance with the GIPS standards. T. Rowe Price has been independently verified for the twenty four-year period ended June 30, 2020, by KPMG LLP. The verification report is available upon request. A firm that claims compliance with the GIPS standards must establish policies and procedures for complying with all the applicable requirements of the GIPS standards. Verification provides assurance on whether the firm’s policies and procedures related to composite and pooled fund maintenance, as well as the calculation, presentation, and distribution of performance, have been designed in compliance with the GIPS standards and have been implemented on a firm-wide basis. Verification does not provide assurance on the accuracy of any specific performance report.

TRP is a U.S. investment management firm with various investment advisers registered with the U.S. Securities and Exchange Commission, the U.K. Financial Conduct Authority, and other regulatory bodies in various countries and holds itself out as such to potential clients for GIPS purposes. TRP further defines itself under GIPS as a discretionary investment manager providing services primarily to institutional clients with regard to various mandates, which include U.S, international, and global strategies but excluding the services of the Private Asset Management group.

A complete list and description of all of the Firm's composites and/or a presentation that adheres to the GIPS® standards are available upon request. Additional information regarding the firm's policies and procedures for calculating and reporting performance results is available upon request

Other Literature

You have successfully subscribed.

Notify me by email when
regular data and commentary is available
exceptional commentary is available
new articles become available

Thank you for your continued interest

Please enter valid search characters

THINKING
Evolving Trade Relations: China and Beyond
THINKING
Unprecedented Global Stimulus and U.S. Policy Impacts on Fixed Income
THINKING
Phase One China Trade Deal: Key Issues Unresolved Until After U.S. Election
THINKING
Coronavirus Pandemic Could Shift Health, Economic Agenda
THINKING
Potential Winners and Losers From Biden’s Climate Plan
THINKING
Rising Tension Between U.S. and China Elevates Trading Issues
THINKING
Higher Tax Rates Expected in Biden Administration
THINKING
Federal Help Wanted: Municipalities Face Fiscal Uncertainties
THINKING
China Becomes a Renewed Target in the 2020 Election
THINKING
Health Care in Crosshairs of Democratic Presidential Race
THINKING
Coronavirus Pandemic Could Shift Health, Economic Agenda
THINKING
Infographic Unprecedented Global Stimulus and U.S. Policy
THINKING
Troubled Small Business Relief Program a Stopgap Measure
THINKING
North American Trade Pact: More Certainty, Muted Impact
THINKING
Senate Runoffs Put Georgia on Investors' Minds
THINKING
What Georgia Senate Results Could Mean for Markets
THINKING
Biden Focus on Regulation Could Have Broad Impact
THINKING
U.S. Election Results Appear Market-Friendly
THINKING
Federal Spending Could Be a Catalyst for Industrials
THINKING
Cooling U.S.-Europe Trade Tensions Could Lead to Bigger Deal
PROFILE
bioImage
  • Years at
    T. Rowe Price3
  • Years investment
    experience3

Katie-Elizabeth-Deal

20 results